Reperfusion rather than ischemia drives the formation of ubiquitin aggregates after middle cerebral artery occlusion. Academic Article uri icon

Overview

abstract

  • BACKGROUND AND PURPOSE: Cerebral ischemia leads to accumulation of ubiquitinated protein aggregates. However, the factors triggering ubiquitination and their impact on the outcome of cerebral ischemia remain poorly understood. Here we investigate the relationship between ubiquitin aggregation and duration of ischemia/reperfusion, infarct volume, and proteasomal activity in a mouse model of focal ischemia. METHODS: Free ubiquitin and ubiquitin aggregate levels were examined by Western blotting in the mouse neocortex and striatum after different periods of ischemia/reperfusion and permanent ischemia induced by middle cerebral artery occlusion. Infarct volumes were measured in thionin-stained brain sections. Proteasome activity was studied by fluorometric peptidase activity assay. RESULTS: Following transient ischemia, ubiquitin aggregates were detected in the ipsilateral neocortex and, to a lesser extent, striatum only after induction of reperfusion. In permanent ischemia, no ubiquitin aggregates were found. Shorter ischemic periods producing no or minimal tissue damage (10-15 minutes) resulted in ubiquitin aggregate levels similar to those produced by ischemia resulting in substantial infarction (30 minutes). Proteasomal impairment was greatest in ischemia without reperfusion, in which no ubiquitin aggregates were detected. CONCLUSIONS: The data demonstrate that reperfusion rather than ischemia leads to the appearance of ubiquitinated aggregates, which form in the absence of major tissue damage and are not correlated with decreased proteasomal peptidase activity. Ubiquitin aggregates may form in potentially viable brain tissue, which may be later recruited into infarction by factors independent of ubiquitination.

publication date

  • June 14, 2012

Research

keywords

  • Brain Ischemia
  • Infarction, Middle Cerebral Artery
  • Reperfusion Injury
  • Ubiquitin

Identity

PubMed Central ID

  • PMC3404229

Scopus Document Identifier

  • 84864277301

Digital Object Identifier (DOI)

  • 10.1161/STROKEAHA.112.650416

PubMed ID

  • 22700531

Additional Document Info

volume

  • 43

issue

  • 8